- Home
- MKTW vs CVM Comparison
MKTW vs CVM Comparison
Compare MKTW & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKTW
- CVM
- Stock Information
- Founded
- MKTW 1999
- CVM 1983
- Country
- MKTW United States
- CVM United States
- Employees
- MKTW N/A
- CVM N/A
- Industry
- MKTW Computer Software: Prepackaged Software
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MKTW Technology
- CVM Health Care
- Exchange
- MKTW Nasdaq
- CVM Nasdaq
- Market Cap
- MKTW 46.9M
- CVM 53.1M
- IPO Year
- MKTW N/A
- CVM 1987
- Fundamental
- Price
- MKTW $17.08
- CVM $7.05
- Analyst Decision
- MKTW Hold
- CVM
- Analyst Count
- MKTW 1
- CVM 0
- Target Price
- MKTW $20.00
- CVM N/A
- AVG Volume (30 Days)
- MKTW 15.2K
- CVM 95.9K
- Earning Date
- MKTW 11-06-2025
- CVM 08-14-2025
- Dividend Yield
- MKTW 4.68%
- CVM N/A
- EPS Growth
- MKTW N/A
- CVM N/A
- EPS
- MKTW 2.55
- CVM N/A
- Revenue
- MKTW $342,206,000.00
- CVM N/A
- Revenue This Year
- MKTW N/A
- CVM N/A
- Revenue Next Year
- MKTW N/A
- CVM N/A
- P/E Ratio
- MKTW $6.71
- CVM N/A
- Revenue Growth
- MKTW N/A
- CVM N/A
- 52 Week Low
- MKTW $9.08
- CVM $1.98
- 52 Week High
- MKTW $21.74
- CVM $32.70
- Technical
- Relative Strength Index (RSI)
- MKTW 61.15
- CVM 37.75
- Support Level
- MKTW $16.12
- CVM $6.86
- Resistance Level
- MKTW $16.88
- CVM $7.44
- Average True Range (ATR)
- MKTW 0.50
- CVM 0.67
- MACD
- MKTW 0.33
- CVM -0.18
- Stochastic Oscillator
- MKTW 88.46
- CVM 30.07
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.